Twitter Beğeni Hilesi

🔬 Join Us at FIN3R Annual Symposium in Helsinki! This week our talented application scientist, Siiri, is presenting her poster on "Vascularized organ-on-chip models for increased biological relevance on a high-throughput platform." #organonchip #microfluidics #drugdiscovery

We will be presenting our work at Teknologia 23 as one of the top 6 startups in Finland for 2023! Visit us at Helsingin Messukeskus to see our CEO Prateek Singh pitch in the finals!

Meet us in Lisbon for the 36th #ADPD conference at our booth 32, and learn about our high throughput blood-brain barrier models 🧫 and key features: - Our capacity to track blood-brain barrier leakage (toxicity, glioblastoma invasion) 🔬 - Neuro-immunology modelling 🔥

Our high-throughput MPS platform has officially reached Japan thanks to 株式会社東京未来スタイル / Tokyo Future Style, Inc. We are excited to have them on board with us.

Simplify complex biological readouts with our high-fidelity impedance spectroscopy and TEER lid. We have made the most compact system for manual and automated use, not only with our platform, but with all legacy transwelll plates! No workstation or dedicated computer required.

Our research and development has been co-funded by the #EU for the advancement of the highly scalable AKITA organ-on-chip platform. This initiative aims at de-risking preclinical drug testing by the development of predictive in vitro models.

We are excited for our new project to reduce reliance on animals for biotech R&D. This is also a significant milestone for us, 5th EU grant in 5 years ☺️

Correction, 6th EU grant. Today we were awarded the EU Horizon grant with cellfatelab AstraZeneca Elvesys — Microfluidics innovation center AMIRES to develop non-animal platform for nanotherapeutics delivery to the brain.